Fact CheckerSign in

NCT07356544Recruiting

Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC

HER2 in Advanced NSCLC: an Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in Italy. The HEROS Study - GOIRC-01-2022

Source: ClinicalTrials.gov · Last updated 5 Mar 2026

Brief summary (registry, in English)

The HEROS study is an Italian observational multicenter prospective study aimed to investigate the current diagnostic and therapeutical approach towards HER2 mutated NSCLC in clinical practice. The enrolment will start in September 2024 until September 2025. A 12-months follow-up window will be performed.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
14 Jan 2025
Start date
12 Aug 2025
Primary completion date
31 Jan 2027
Lead sponsor
Gruppo Oncologico Italiano di Ricerca Clinica
Diseases
Lung cancer
NCT number
NCT07356544

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 12 Aug 2025 to the primary completion date, 31 Jan 2027
  • 22 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \-

Who the study is looking for

  • Cohort 1 (Prevalence study population)
  • Male or female, aged at least 18 years.
  • Pathologically confirmed diagnosis of NSCLC from September 2024 to September 2025.
  • Locally advanced (IIIC), not amenable to multimodal approach (chemo-radiotherapy), or metastatic (IV) NSCLC according to TNM VIII edition.
  • Enrolled in ATLAS project. Cohort 2 (HER2 mutations study population)
  • Included in Cohort 1.
  • Presence of HER2 mutation.
  • Enrolled in ATLAS project. Cohort 3 (Prospective Biomarker Analysis population)
  • Included in Cohort 2.
  • Availability of tissue sample from the first 50 patients enrolled in cohort 2.
  • Written informed consent (HEROS project) must be obtained before any study-related procedure.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (22)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centro di Riferimento Oncologico IRCCS di Aviano
Coordinator of this site? Confirm its status
AvianoItalyNot yet recruiting
IRCCS "Giovanni Paolo II"
Coordinator of this site? Confirm its status
BariItalyActive, not recruiting
Arcispedale Sant'Anna
Coordinator of this site? Confirm its status
FerraraItalyNot yet recruiting
Ospedale Policlinico San Martino
Coordinator of this site? Confirm its status
GenovaItalyNot yet recruiting
Ospedale Versilia
Coordinator of this site? Confirm its status
Lido di CamaioreItalyActive, not recruiting
Azienda Sanitaria Toscana Nord - Ovest
Coordinator of this site? Confirm its status
LuccaItalyActive, not recruiting
Istituto Romagnolo per lo Studio dei Tumori IRST "Dino Amadori"
Coordinator of this site? Confirm its status
MeldolaItalyNot yet recruiting
ASST Grande Ospedale Metropolitano Niguarda
Coordinator of this site? Confirm its status
MilanItalyNot yet recruiting
IRCCS Ospedale San Raffaele
Coordinator of this site? Confirm its status
MilanItalyNot yet recruiting
Azienda Ospedaliero - Universitaria di Modena
Coordinator of this site? Confirm its status
ModenaItalyActive, not recruiting
IRCCS San Gerardo dei Tintori
Coordinator of this site? Confirm its status
MonzaItalyNot yet recruiting
AOU San Luigi Orbassano
Coordinator of this site? Confirm its status
OrbassanoItalyNot yet recruiting
Istituto Oncologico Veneto - IRCCS
Coordinator of this site? Confirm its status
PadovaItalyRecruiting
Azienda Ospedaliera - Universitaria di Parma
Coordinator of this site? Confirm its status
ParmaItalyRecruiting
Fondazione IRCCS Policlinico S. Matteo
Coordinator of this site? Confirm its status
PaviaItalyNot yet recruiting
Azienda Ospedaliera di Perugia
Coordinator of this site? Confirm its status
PerugiaItalyActive, not recruiting
Azienda Ospedaliero - Universitaria di Reggio Emilia
Coordinator of this site? Confirm its status
Reggio EmiliaItalyActive, not recruiting
Azienda Ospedaliera San Camillo Forlanini
Coordinator of this site? Confirm its status
RomaItalyActive, not recruiting
Istituto Nazionale dei Tumori Regina Elena IRCCS - IFO
Coordinator of this site? Confirm its status
RomaItalyNot yet recruiting
Istituto Clinico Humanitas IRRCS
Coordinator of this site? Confirm its status
RozzanoItalyNot yet recruiting
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC)
Coordinator of this site? Confirm its status
UdineItalyNot yet recruiting
Azienda Ospedaliera Universitaria Integrata Verona
Coordinator of this site? Confirm its status
VeronaItalyNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.